| Literature DB >> 32423091 |
Ilona Krabicová1, Silvia Lucia Appleton2, Maria Tannous2, Gjylije Hoti2, Fabrizio Caldera2, Alberto Rubin Pedrazzo2, Claudio Cecone2, Roberta Cavalli3, Francesco Trotta2.
Abstract
Nowadays, research in the field of nanotechnology and nanomedicine has become increasingly predominant, focusing on the manipulation and development of materials on a nanometer scale. Polysaccharides have often been used as they are safe, non-toxic, hydrophilic, biodegradable and are low cost. Among them, starch derivatives and, in particular, cyclodextrin-based nanosponges (CD NSs) have recently emerged due to the outstanding properties attributable to their peculiar structure. In fact, alongside the common polysaccharide features, such as the presence of tunable functional groups and their ability to interact with biological tissues, thus giving rise to bioadhesion, which is particularly useful in drug delivery, what makes CD NSs unique is their three-dimensional network made up of crosslinked cyclodextrin units. The name "nanosponge" appeared for the first time in the 1990s due to their nanoporous, sponge-like structure and responded to the need to overcome the limitations of native cyclodextrins (CDs), particularly their water solubility and inability to encapsulate charged and large molecules efficiently. Since CD NSs were introduced, efforts have been made over the years to understand their mechanism of action and their capability to host molecules with low or high molecular weight, charged, hydrophobic or hydrophilic by changing the type of cyclodextrin, crosslinker and degree of crosslinking used. They enabled great advances to be made in various fields such as agroscience, pharmaceutical, biomedical and biotechnological sectors, and NS research is far from reaching its conclusion. This review gives an overview of CD NS research, focusing on the origin and key points of the historical development in the last 50 years, progressing from relatively simple crosslinked networks in the 1960s to today's multifunctional polymers. The approach adopted in writing the present study consisted in exploring the historical evolution of NSs in order to understand their role today, and imagine their future.Entities:
Keywords: crosslinked polymer; cyclodextrin nanosponge; history
Year: 2020 PMID: 32423091 PMCID: PMC7285114 DOI: 10.3390/polym12051122
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Number of papers on cyclodextrin-based nanosponges (CD NSs) published over the years from 1999 until 2019.
Figure 2Research areas in which CD NSs are involved.
Historical excursus of publications on CD-based NSs employed in pharmaceutical research.
| Year | Nanosponge/Cross-Linker | Drug | Indication | References |
|---|---|---|---|---|
| 2010–2015 | β-CD/DPC | Camptothecin | Pharmaceutical application | [ |
| β-CD/CDI | Resveratrol | Pharmaceutical application | [ | |
| Fluorescent NS | Paclitaxel | Pharmaceutical application | [ | |
| Carboxylated nanosponges | Acyclovir | Antivirial efficacy | [ | |
| β-CD/CDI | Rutin, phloridzin and chlorogenic acid | Anti-cancer, anti-diabetic, antiobesity, neuronal protective properties etc. | [ | |
| β-CD/DPC | Gabapentin | Treatment of partial seizures in pediatric | [ | |
| 2016 | β-CD/PMDA | Lansoprazole | Gastric ulcers | [ |
| β-CD/DPC | Quercetin | Cancer treatment | [ | |
| β-CD /CDI | Erlotinib hydrochloride (ERL) | Cancer treatment | [ | |
| GSH–NS (β-CD/PMDA) | Doxorubicin | Anticancer activity | [ | |
| 2017 | β-CD/EDTA | Ibuprofen | diseases | [ |
| β-CD/DPC | 2-(3,4-dimethoxyphenyl)-3-phenyl-4H-pyrido [1,2-a] pyrimidin-4-one (DB103) | Cardiovascular diseases, drug-eluting stents (DES) | [ | |
| β-CD/DPC | Chrysin | Optimal anti-oxidant and anti-tumorous properties | [ | |
| β-CD/DPC | Nifedipine | Treatment of angina pectoris and hypertension | [ | |
| β-CD/CDI | Camptothecin (CPT) | Antitumor efficacy, inhibition effect on prostate cancer | [ | |
| β-CD/DPC | Cefadroxil (CFD) | Against variety of Gram-positive and Gram-negative bacteria | [ | |
| β-CD/DPC | Efavirenz and Rilpivirine HCl | HIV | [ | |
| β-CD/PMDA | Erlotinib glutathione | Cancer | [ | |
| 2018 | β-CD/DMC | Ellagic acid | Cancer | [ |
| β-CD/DPC | Mebendazole | Lymphatic worm infestations | [ | |
| β-CD/TDI | Naproxen | Inflammation | [ | |
| Electrospun | Infectious diseases | [ | ||
| β-CD/PMDA | ||||
| β-CD/CDI; PMDA | Rilpivrine | HIV | [ | |
| β-CD/CDI | Atorvastatin calcium | Dyslipidemia | [ | |
| β-CD/DPC | Norfloxacin | Urinary tract infections | [ | |
| β-CD/CDI | Doxorubicin | Cancer | [ | |
| 2019 | β-CD/NDCA | Sage essential oil | Diabetes | [ |
| β-CD/DPC; PMDA | Curcumin and Resveratrol | Cancer | [ | |
| β-CD / DPC | Ferulic acid and Imatinib Mesylate | Cancer | [ | |
| β-CD/EPI | Curcumin | Cancer | [ | |
| β-CD/CDI | Kynurenic acid and Paliperidone | Neurological disorders and Schizophrenia | [ | |
| β-CD/PMDA | Imiquimod | Topical diseases | [ |
Historical excursus of publications on CD-based NSs employed in food, textile, environmental fields, etc.
| Years | Nanosponge/Crosslinker | Adsorbate | Field | References |
|---|---|---|---|---|
| 1980–2000 | CDs/HMDI, phenyl isocyanate, EPI | Naringin, limonin, debittering of grapefruit juice, | Food | [ |
| CDs/EPI | Caffeine, vanillin and theobromine | [ | ||
| CDs / EPI, HMDI and Phenyl isocyanate | Textile dyes | Textile | [ | |
| Aromatic pollutants, such as phenol, | Environment | [ | ||
| CDs/HMDI or toluene 2,6-diisocyanate | Organic pollutants | Water Treatment (Environment) | [ | |
| 2000–2009 | β-CD/EPI | Naphthalene, 2-naphthol and naproxen | Water Treatment (Environment) | [ |
| CDs/CDI, DMC | Chlorinated persistent organic pollutants (POPs) | Water Treatment (Environment) | [ | |
| CD/HMDI or toluene-2,4-diisocyanate | p-nitrophenol and pentachlorophenol, | [ | ||
| β-CD/PMDA | Heavy metals (Al (III), Mn (II), Co (II), Ni (II), Cu (II), Cd (II) etc.) | Water Treatment (Environment) | [ | |
| Carcinogenic N-nitrosodimethylamine (NDMA) | Water Treatment (Environment) | [ | ||
| Carbonate NSs | Increase the thermostability, pH stability and storage stability of catechol 1,2-dioxygenase | As a substrate for enzyme immobilization | [ | |
| 2010–2019 | β-CD/DPC | Phosphorus derivatives | Flame retardancy | [ |
| α, β, γ-CD / CDI; PMDA | Oxygen | Hypoxia/Reoxygenation and Biomedical application | [ | |
| β-CD /CDI | Oxygen, carbon dioxide and 1-methylcyclopropene 1-MCP carriers. | biomedical, environmental and floriculture application | [ | |
| β-CD/PMDA | Iron fertilizer | Agricultural application | [ | |
| CD/DPC | Xanthene derivatives | Catalytic Activity | [ | |
| CD/CDI | Coriander essential oil | food packaging | [ |
Figure 3Hierarchy analysis approach to choose the best cross-linker.
Figure 4Timeline of the historical development of cyclodextrin-based nanosponges.